Oncology & Cancer

A potential new therapeutic target for Ewing sarcoma

The sarcoma research group of the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Òscar Martínez-Tirado, has identified a potential new therapeutic target for Ewing sarcoma, the second most frequent bone cancer ...

Oncology & Cancer

Team finds link between BRCA1 and Ewing sarcoma

Scientists with the Greehey Children's Cancer Research Institute at UT Health San Antonio have discovered a surprising connection between a breast cancer protein, BRCA1, and a pediatric cancer called Ewing sarcoma.

Oncology & Cancer

New procedure brings chemo to melanoma

The choice between saving one's limb or one's life may seem obvious. However, surgical oncologist Cristina O'Donoghue, MD, MPH, knows the decision is emotionally wrenching for patients with advanced melanoma or sarcoma in ...

Oncology & Cancer

For cancer patients with HIV, immunotherapy appears safe

A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from ...

Oncology & Cancer

Two classes of GGAA-microsatellites in a Ewing sarcoma context

In a study published in PLOS ONE, researchers describe two types of GGAA-microsatellites and their roles in EWS/FLI binding and gene regulation in Ewing sarcoma. Ewing sarcoma is the second most common pediatric bone malignancy. ...

Oncology & Cancer

In Norway, risk of SCC after organ transplant has fallen

(HealthDay)—For organ recipients in Norway, the risk of skin cancer, particularly squamous cell carcinoma (SCC), has decreased since the mid-1980s, according to a study published online Oct. 18 in JAMA Dermatology.

Oncology & Cancer

Boosting sarcoma cell death

Ewing sarcomas – rare, aggressive childhood cancers – are derived from mesenchymal cells in bone and soft tissues, and children with metastatic disease have poor survival.

page 8 from 16